GSK’s shingles vaccine gets thumbs up in North America
Inoculation slated to be a blockbuster
GlaxoSmithKline has gained US and Canadian regulatory approval for its shingles vaccine, Shingrix.
Inoculation slated to be a blockbuster
GlaxoSmithKline has gained US and Canadian regulatory approval for its shingles vaccine, Shingrix.